P43405 (KSYK_HUMAN) Homo sapiens (Human)

Tyrosine-protein kinase SYK UniProtKBInterProSTRINGInteractive Modelling

635 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

87 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
The tandem SH2 domains of SYK with a bound CD3G diphospho-ITAM peptide
7q5u
 Heteromer
P09693; 		6-262
2×EDO; 1×PEG; 1×P4G;
Assess
The tandem SH2 domains of SYK with a bound FCER1G diphospho-ITAM peptide
7q5t
 Heteromer
P30273; 		8-262
2×PO4; 1×EDO;
Assess
The tandem SH2 domains of SYK with a bound TYROBP diphospho-ITAM peptide
7q5w
 Heteromer
O43914; 		9-262
1×PO4; 1×EDO;
Assess
CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLA…
1a81
 Heteromer
P07766; 		9-262
Assess
Crystal structure of c-Cbl-TKB domain complexed with its binding motif in Syk
3buw
 Heteromer
P22681; 		319-327
Assess
Crystal structure of Syk catalytic domain in complex with a furo[3,2-d]pyrimidine
5t68
homo-2-mer363-635
2×77V;
Assess
Structural and Biophysical Characterization of the Syk Activation Switch
4fl3
monomer9-635
1×ANP; 1×MG;
Assess
Structural and Biophysical Characterization of the Syk Activation Switch
4fl2
monomer9-635
1×MG; 1×ANP;
Assess
SYK catalytic domain in complex with a potent triazolopyridine inhibitor
4wnm
monomer347-635
1×3RT; 1×SO4;
Assess
Discovery of TAK-659, an Orally Available Investigational Inhibitor of Spleen Tyrosine Kinase (SYK)
5tt7
monomer358-635
1×7KF;
Assess
SYK catalytic domain complexed with a potent and orally bioavailable benzisothiazole inhibitor
5cy3
monomer360-635
1×55Y;
Assess
Crystal structure of SYK kinase domain with 1-benzyl-N-(5-(6,7-dimethoxyquinolin-4-yloxy)pyridin-2-…
3tuc
monomer358-633
1×FPW;
Assess
Discovery of TAK-659, an Orally Available Investigational Inhibitor of Spleen Tyrosine Kinase (SYK)
5tr6
monomer362-635
1×7KG; 1×EDO;
Assess
Crystal structure of spleen tyrosine kinase complexed with N-{(S)-1-[7-(3,4-Dimethoxy-phenylamino)-…
4fyo
monomer363-635
1×0VF;
Assess
SYK Kinase domain in complex with azabenzimidazole inhibitor 3
6zcs
monomer363-635
1×QFE;
Assess
Crystal structure of SYK kinase domain with inhibitor
5tiu
monomer363-635
1×7CU;
Assess
Syk kinase domain in complex with macrocyclic inhibitor 20a
8bi2
monomer363-635
1×QR7;
Assess
Crystal structure of the syk tyrosine kinase domain with Gleevec
1xbb
monomer363-635
1×STI;
Assess
SYK Kinase domain in complex with azabenzimidazole inhibitor 18
6zcx
monomer363-635
1×QFQ;
Assess
Crystal structure of spleen tyrosine kinase complexed with 2-(5,6,7,8-Tetrahydro-imidazo[1,5-a]pyri…
4i0t
monomer363-635
1×1B6;
Assess
SYK catalytic domain complexed with naphthyridine inhibitor
5cxz
monomer363-635
1×GOL; 1×CL; 1×55U;
Assess
syk in complex with 57262_SYKB-AZ13344324-2
6zcu
monomer363-635
1×5JG;
Assess
SYK Kinase domain in complex with azabenzimidazole inhibitor 7
6zcr
monomer363-635
1×5JG;
Assess
Crystal structure of spleen tyrosine kinase complexed with 6-((1R,2S)-2-Amino-cyclohexylamino)-4-(6…
4fz7
monomer363-635
1×0VH;
Assess
SYK Catalytic Domain Complexed with a Potent Pyrimidine Inhibitor
4rx9
monomer363-635
1×GOL; 1×3YT;
Assess
Structural and Biophysical Characterization of the Syk Activation Switch
4fl1
monomer363-635
1×ANP; 1×MG;
Assess
SYK Catalytic Domain Complexed with a Potent Triazine Inhibitor
4rx7
monomer363-635
1×FMT; 1×GOL; 1×3YV;
Assess
Crystal structures of spleen tyrosine kinase in complex with a novel inhibitor
5y5t
monomer363-635
1×8OR;
Assess
SYK Kinase domain in complex with diamine inhibitor 16
6zcy
monomer363-635
1×QF8;
Assess
Crystal structure of spleen tyrosine kinase complexed with [6-((S)-2-Methyl-pyrrolidin-1-yl)-pyridi…
4fz6
monomer363-635
1×0VG;
Assess
SYK catalytic domain complexed with a potent orally bioavailable thiazole inhibitor
5cxh
monomer363-635
1×55M;
Assess
Crystal structure of SYK in complex with compound 1
5c26
monomer363-635
1×50H;
Assess
SYK Kinase domain in complex with azabenzimidazole inhibitor 2b
6zc0
monomer363-635
1×QDZ;
Assess
Crystal structure of spleen tyrosine kinase complexed with 2-(6-Chloro-1-methyl-1H-indazol-3-yl)-5H…
4i0s
monomer363-635
1×1B5;
Assess
Crystal structure of spleen tyrosine kinase complexed with a sulfonamidopyrazine piperidine inhibit…
4dfl
monomer363-635
1×0K0; 1×EDO; 1×SO4;
Assess
Crystal structure of spleen tyrosine kinase (Syk) in complex with an imidazopyrazine inhibitor
4pv0
monomer363-635
1×CG4; 5×CL;
Assess
Crystal structure of apo syk tyrosine kinase domain
1xba
monomer363-635
Assess
Crystal structure of the syk tyrosine kinase domain with Staurosporin
1xbc
monomer363-635
1×STU;
Assess
syk in complex with compound 30
6ssb
monomer363-635
1×LUE;
Assess
Crystal Structure of Spleen Tyrosine Kinase Syk Catalytic Domain with Pyrazolylbenzimidazole Inhibi…
3vf8
monomer363-635
1×0JE;
Assess
Crystal structure of spleen tyrosine kinase complexed with R406
3fqs
monomer363-635
1×585;
Assess
Crystal structure of spleen tyrosine kinase complexed with 2-(3,4,5-Trimethoxy-phenyl)-5H-pyrrolo[2…
4i0r
monomer363-635
1×1B4;
Assess
Crystal structure of SYK in complex with compound 2
5c27
monomer363-635
1×50J; 1×GOL;
Assess
SYK Kinase domain in complex with azabenzimidazole inhibitor 2b
6zcp
monomer363-635
1×QFK;
Assess
Crystal structure of an inhibitor-bound Syk
4xg4
monomer363-635
1×X4G;
Assess
Crystal structure of spleen tyrosine kinase complexed with 3-(8-{4-[Ethyl-(2-hydroxy-ethyl)-amino]-…
4fyn
monomer363-635
1×0VE;
Assess
SYK Kinase domain in complex with diamine inhibitor 5
6zcq
monomer363-635
1×QFB;
Assess
Crystal structure of SYK kinase domain with N-(4-methyl-3-(8-methyl-7-oxo-2-(phenylamino)-7,8-dihyd…
3tud
monomer363-635
1×FPX;
Assess
Crystal structure of spleen tyrosine kinase complexed with r9021
4gfg
monomer363-635
1×0XF;
Assess
Crystal structure of an inhibitor-bound Syk
4xg6
monomer363-635
1×X6G;
Assess
Crystal structure of spleen tyrosine kinase complexed with an adamantylpyrazine inhibitor
4dfn
monomer363-635
1×0K1;
Assess
Crystal structure of spleen tyrosine kinase complexed with YM193306
3fqe
monomer363-635
1×P5C;
Assess
Crystal structure of an inhibitor-bound Syk
5ghv
monomer363-635
1×X5G;
Assess
SYK Catalytic Domain Complexed with a Potent Triazine Inhibitor2
4rx8
monomer364-635
2×GOL; 1×3YX;
Assess
SYK catalytic domain in complex with a potent pyridopyrimidinone inhibitor
4px6
monomer364-635
1×2X6;
Assess
Crystal structure of an inhibitor-bound Syk
4xg7
monomer364-635
1×X7G;
Assess
Crystal structure of ligand-free Syk
4xg2
monomer364-635
Assess
Crystal structure of SYK kinase domain with 1-(5-(6,7-dimethoxyquinolin-4-yloxy)pyridin-2-yl)-3-((1…
3tub
monomer362-633
1×FPU;
Assess
Crystal structure of spleen tyrosine kinase complexed with a 2-substituted 7-azaindole
3fqh
monomer363-634
1×057;
Assess
Crystal Structure of Spleen Tyrosine Kinase Syk Catalytic Domain with Thienopyrazolylindole Inhibit…
3vf9
monomer364-635
1×477;
Assess
Crystal structure of an inhibitor-bound Syk
4xg3
monomer363-634
1×X3G;
Assess
CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH A 2-(PHENOXYMETHYL)PYRIDINE INHIB…
6hm7
monomer363-633
1×GDH; 3×BR; 1×GOL; 1×DMS;
Assess
Crystal structure of tyrosine-protein kinase SYK with an inhibitor
4rss
monomer364-634
1×4MG;
Assess
Crystal structure of spleen tyrosine kinase (SYK) in complex with a diaminopyrimidine carboxamide i…
3srv
monomer364-634
1×S19; 3×GOL;
Assess
HUMAN SPLEEN TYROSINE KINASE KINASE DOMAIN IN COMPLEX WITH AZANAPHTHYRIDINE INHIBITOR
5lmb
monomer364-634
1×6ZF; 5×GOL;
Assess
Crystal structure of spleen tyrosine kinase (Syk) in complex with GS-9973
4puz
monomer363-633
1×CG9;
Assess
Crystal structures of spleen tyrosine kinase in complex with a novel inhibitor
5y5u
monomer364-634
1×8OU;
Assess
SYK in COMPLEX WITH LIGAND LASW836
4f4p
monomer365-635
1×0SB; 1×SO4;
Assess
SYK kinase domain in complex with inhibitor GTC000225
4yjr
monomer364-633
1×4DJ;
Assess
SYK kinase domain in complex with inhibitor GTC000224
4yjq
monomer364-633
1×4DK;
Assess
HUMAN SPLEEN TYROSINE KINASE KINASE DOMAIN IN COMPLEX WITH AZANAPHTHYRIDINE INHIBITOR
5lma
monomer363-632
1×6ZG; 2×GOL; 1×DMS;
Assess
THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000233
4yjt
monomer364-633
1×GOL; 1×4DQ;
Assess
THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000222
4yjo
monomer363-632
1×4DF; 1×GOL;
Assess
THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000250
4yjv
monomer364-633
1×4DT;
Assess
THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000249
4yju
monomer364-633
1×4DO;
Assess
The Crystal Structure of SYK from Biortus.
8x5k
monomer363-632
1×3YT; 1×EDO;
Assess
Crystal structure of an inhibitor-bound Syk
4xg8
monomer366-635
1×X8G;
Assess
Crystal structure of an inhibitor-bound Syk
4xg9
monomer363-632
1×X9G;
Assess
THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000223
4yjp
monomer364-632
1×4DL; 1×DMS;
Assess
CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH A 2-(PYRIDINYLOXYMETHYL)PYRIDINE …
6hm6
monomer364-632
1×GDK; 1×GOL;
Assess
THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000226
4yjs
monomer364-632
1×4DN;
Assess
Crystal structure of Syk in complex with GS-9876
6vov
monomer363-629
1×R6D;
Assess
Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyro…
3emg
monomer365-631
1×685;
Assess
The tandem SH2 domains of SYK
7q63
monomer6-263
1×PEG; 3×SCN; 1×CL;
Assess
Crystal structure of the apo SH2 domains of Syk
7sa7
monomer9-262
Assess
SYK TYROSINE KINASE C-TERMINAL SH2 DOMAIN COMPLEXED WITH A PHOSPHOPEPTIDEFROM THE GAMMA CHAIN OF TH…
1csz
monomer162-265
Assess
SYK TYROSINE KINASE C-TERMINAL SH2 DOMAIN COMPLEXED WITH A PHOSPHOPEPTIDEFROM THE GAMMA CHAIN OF TH…
1csy
monomer162-265
Assess

4 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4fl2.1.Amonomer0.789-635
1×MG; 1×ANP;100.00
Assess
1y57.1.Amonomer0.61160-633
35.64
Assess
1opl.2.Amonomer0.60162-632
38.16
Assess
4k11.1.Amonomer0.60161-633
35.47
Assess

4 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 24fl2.1.Amonomer0.809-612
1×MG; 1×ANP;100.00
Assess
Isoform 21y57.1.Amonomer0.65160-610
35.11
Assess
Isoform 21opl.2.Amonomer0.64162-609
38.68
Assess
Isoform 21opl.1.Amonomer0.64157-609
38.68
Assess